article thumbnail

Signal: UK Biobank raises £32m in funding via public-private partnership

Pharmaceutical Technology

Eric Schmidt and Ken Griffin have led the UK Biobank funding round, donating a government-matched $10m each that may be used for AI.

article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK Biobank releases largest-ever genome sequencing dataset

pharmaphorum

UK Biobank releases largest-ever genome sequencing dataset Phil.Taylor Thu, 30/11/2023 - 10:00 Bookmark this

article thumbnail

UK Biobank study “will shape drug discovery”

pharmaphorum

UK Biobank study “will shape drug discovery” Phil.Taylor Thu, 05/10/2023 - 10:09 Bookmark this

article thumbnail

New UK biobank offers stem cell and regenerative medicine research potential  

Drug Discovery World

BioGrad, a company offering medical and scientific support for education and research organisations, is to open the UK’s second largest biobank facility in Liverpool, as part of a £7.6m The post New UK biobank offers stem cell and regenerative medicine research potential appeared first on Drug Discovery World (DDW).

article thumbnail

Supercharging AI-drug discovery with strategic multiomic biobanks 

Drug Discovery World

Narain , PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market. Not all biobanks are created equal Biobanks provide a treasure trove of clinical data for exploration with AI tools. But the utility of biobanks varies.

article thumbnail

UK Agency targets blood thinners in personalised medicine pursuit

Pharmaceutical Technology

The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.